Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Cholestasis, Jaundice, Obstructive
Interventions: SMOFlipid; Drug
Lead sponsor: University of Florida; Other
Eligibility: 23 Weeks to 1 Year
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: low carbohydrate/high fat diet, low fat/high carbohydrate diet; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypertriglyceridemia
Interventions: Omega-3-acid ethyl esters, Placebo; Drug
Lead sponsor: Babu Balagopal; Other
Eligibility: 10 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 3
States / cities: Wilmington, Delaware • Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: TBI
Interventions: Omega 3 fatty acid, Safflower seed oil; Drug · Dietary Supplement
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Amblyopia
Interventions: Docosahexaenoic Acid, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 3 Years to 17 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy
Interventions: Fish Oil, Safflower Oil, Ethanol, Omega-3 polyunsaturated fatty acids, Omega-6 polyunsaturated fatty acid; Drug · Dietary Supplement
Lead sponsor: Carsten Skarke, MD; Other
Eligibility: 21 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Heart Disease
Interventions: EPA 600, EPA 1800, Olive Oil, DHA; Dietary Supplement
Lead sponsor: Cardiovascular Research Associates; Network
Eligibility: 21 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ductal Breast Carcinoma in Situ, Breast Cancer, Stage I, Breast Cancer, Stage II, Breast Cancer, Stage III
Interventions: omega-3 fatty acid, placebo, Questionnaire administration; Dietary Supplement · Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days
Interventions: Smoflipid 20% (investigational lipid for parenteral nutrition), Intralipid® 20%; Drug
Lead sponsor: Fresenius Kabi; Industry
Eligibility: 0 Weeks and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 13
States / cities: Palo Alto, California • San Diego, California • New Haven, Connecticut + 8 more

Conditions: Diabetes Mellitus, Type 2
Interventions: ORMD-0801, Placebo; Drug · Other
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Tustin, California

Conditions: Subconcussive Head Impact, Omega-3 Fatty Acids
Interventions: Omega-3 Fatty Acids (EPA plus DHA), Organic soybean oil, Soccer Heading Model; Dietary Supplement · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Benign Breast Neoplasm, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Lobular Breast Carcinoma In Situ, Paget Disease of the Breast, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Docosahexaenoic Acid, Placebo; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 4
States / cities: Boston, Massachusetts • New York, New York • Houston, Texas

Conditions: Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis
Interventions: Omegaven™; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Cholestasis, Growth Failure
Interventions: SMOFlipid; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Days to 1 Year
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Control, Omega 3 fatty acids; Dietary Supplement
Lead sponsor: University of Arkansas, Fayetteville; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
Interventions: Omega-3 fatty acid, Celecoxib; Dietary Supplement · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Vestibular Schwannoma
Interventions: Omega-3, Placebo; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mood Disturbance, Mood Disorders, Natural Supplements, Alternative Treatment
Interventions: Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 17 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne
Interventions: Omega-3, Placebo; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 70 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Sickle Cell Disease
Interventions: Docosahexaenoic Acid, Placebo; Drug
Lead sponsor: Micelle BioPharma Inc; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 11
States / cities: Birmingham, Alabama • Oakland, California • Gainesville, Florida + 8 more

Conditions: HIV Infection
Interventions: Fish oil that contains omega-3 fatty acids, Placebo; Dietary Supplement
Lead sponsor: Rush University Medical Center; Other
Eligibility: 40 Years to 70 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Ischemic Stroke, Transient Ischemic Attack
Interventions: omega-3 polyunsaturated fatty acids (Lovaza); Dietary Supplement
Lead sponsor: Millard Fillmore Gates Hospital; Other
Eligibility: 25 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Healthy Volunteers, Markers of Cardiovascular Risk
Interventions: SDA soybean oil-containing foods, High-oleic sunflower oil containing foods, Eicosapentaenoic acid; Other
Lead sponsor: Monsanto Company, LLC; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: St. Petersburg, Florida • Addison, Illinois

Conditions: Health Effects of Ambient Air Pollution
Interventions: omega-3 fatty acids; Dietary Supplement
Lead sponsor: U.S. EPA Human Studies Facility; Federal
Eligibility: 25 Years to 55 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

SMOFlipid to Lessen the Severity of Neonatal Cholestasis

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

Fish Oil Study for High Triglyceride Levels in Children

Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Omega-3 Fatty Acids and Subconcussive Head Impacts

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury

Breakfast and Energy Expenditure in Young Women

Window of Opportunity Study Targeting the Inflammatory Milieu

Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma

A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

Dose-Finding Study of SC411 in Children With Sickle Cell Disease

Fish Oil for HIV-Related Inflamm-aging and Immune Senescence

Lovaza's Effect on Clopidogrel in a Neuro Population

Efficacy Study of Stearidonic Acid (SDA) Soybean Oil-containing Foods on Red Blood Cell Fatty Acid Content

Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults